CompletedNCT00226343
Divalproex compared with placebo for depression in bipolarity
About this title
Depakote-ER for Depressive and Bipolar Depression
Read the official source — NCT00226343Medication studyAges 18–65
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateAugust 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- Cambridge Health Alliance
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Not clearly listed
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00226343
- Official title
Show the full official title
Phase 4 Study: Double-blind Placebo-controlled Trial of Depakote-ER for Depressive and Anxiety Symptoms in Non-refractory Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Locations not listed
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Cambridge Health Alliance.
Did this study involve medication?
Yes. The study involved medication, including Depakote-ER.
Who was this study for?
Listed age limits: 18 years to 65 years.
